Clinical trial
Treatment of Refractory Status Epilepticus
NCT00265616 · Brigham and Women's Hospital, Other · Terminated
Key facts
| NCT number | NCT00265616 |
|---|---|
| Title | Treatment of Refractory Status Epilepticus |
| Official title | A Randomized Clinical Trial for the Treatment of Refractory Status Epilepticus |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Status Epilepticus |
| Intervention type | Drug |
| Interventions | propofol, thiopental/pentobarbital |
| Enrollment | 23 |
| Start date | May 1, 2006 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Dec 15, 2005 |
| Last update posted | Apr 9, 2013 |
| Countries | Switzerland, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: